https://www.selleckchem.com/products/tpx-0046.html
Rationale It is very difficult to treat patients with aplastic anemia accompanied by chronic kidney disease. The nephrotoxicity of cyclosporine limits its use in these patients. Most of these patients also lack suitable sibling donors. Sirolimus, as a new type of immunosuppressive agent, has good therapeutic effect, lower toxicity, especially lower nephrotoxicity, thus attracting the attention of hematologists. Patient concerns This 55-year-old Chinese male patient suffered from pancytopenia and renal insufficiency and has a poor quali
Like
Comment
Share
